Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Immediacy Index: 0.927
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 1007
  • Print this page
  • Email this page

  Reader Comments

Year : 2022 | Volume:  15 | Issue Number:  7

REVIEW ARTICLE

Conventional treatments and non-PEGylated liposome encapsulated doxorubicin for visceral leishmaniasis: A scoping review

Satapathy Soumya Ranjan, Sahoo Rudra Narayan

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks


 

Back To Article